JP2008063322A5 - - Google Patents

Download PDF

Info

Publication number
JP2008063322A5
JP2008063322A5 JP2007194146A JP2007194146A JP2008063322A5 JP 2008063322 A5 JP2008063322 A5 JP 2008063322A5 JP 2007194146 A JP2007194146 A JP 2007194146A JP 2007194146 A JP2007194146 A JP 2007194146A JP 2008063322 A5 JP2008063322 A5 JP 2008063322A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
disease caused
hyperuricemia
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007194146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008063322A (ja
JP5226980B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2007194146A priority Critical patent/JP5226980B2/ja
Priority claimed from JP2007194146A external-priority patent/JP5226980B2/ja
Publication of JP2008063322A publication Critical patent/JP2008063322A/ja
Publication of JP2008063322A5 publication Critical patent/JP2008063322A5/ja
Application granted granted Critical
Publication of JP5226980B2 publication Critical patent/JP5226980B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2007194146A 2006-08-10 2007-07-26 ＨＭＧ−ＣｏＡリダクターゼ阻害剤、トコフェロール類及びＣｏＱ１０を含有する医薬組成物 Expired - Fee Related JP5226980B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007194146A JP5226980B2 (ja) 2006-08-10 2007-07-26 ＨＭＧ−ＣｏＡリダクターゼ阻害剤、トコフェロール類及びＣｏＱ１０を含有する医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006217657 2006-08-10
JP2006217657 2006-08-10
JP2007194146A JP5226980B2 (ja) 2006-08-10 2007-07-26 ＨＭＧ−ＣｏＡリダクターゼ阻害剤、トコフェロール類及びＣｏＱ１０を含有する医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012252097A Division JP2013032400A (ja) 2006-08-10 2012-11-16 ＨＭＧ−ＣｏＡリダクターゼ阻害剤、トコフェロール類及びＣｏＱ１０を含有する医薬組成物２

Publications (3)

Publication Number Publication Date
JP2008063322A JP2008063322A (ja) 2008-03-21
JP2008063322A5 true JP2008063322A5 (ru) 2010-07-29
JP5226980B2 JP5226980B2 (ja) 2013-07-03

Family

ID=39286323

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007194146A Expired - Fee Related JP5226980B2 (ja) 2006-08-10 2007-07-26 ＨＭＧ−ＣｏＡリダクターゼ阻害剤、トコフェロール類及びＣｏＱ１０を含有する医薬組成物

Country Status (1)

Country Link
JP (1) JP5226980B2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012096998A (ja) * 2009-02-27 2012-05-24 Kowa Co 安定なカプセル製剤及びその製造方法
TWI636783B (zh) * 2012-04-18 2018-10-01 友霖生技醫藥股份有限公司 含匹伐他汀（ｐｉｔａｖａｓｔａｔｉｎ）穩定配方的醫藥組合物
WO2022129004A1 (en) * 2020-12-15 2022-06-23 Dsm Ip Assets B.V. Coated statin tablet comprising vitamin e acetate powder
WO2022129003A1 (en) * 2020-12-15 2022-06-23 Dsm Ip Assets B.V. Multiparticulate solid oral dosage form comprising statin and vitamin e

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1285650B1 (en) * 2000-05-09 2016-07-27 Kaneka Corporation Method and compositions for inhibiting arteriosclerosis
JP2002363073A (ja) * 2001-05-09 2002-12-18 Crescendo Corporation スポーツパフォーマンス
JP2005187454A (ja) * 2003-12-05 2005-07-14 Sankyo Co Ltd ビタミンｅ含有ｌｄｌ低下剤及び／又は動脈硬化抑制剤組成物
JP2005225870A (ja) * 2004-01-16 2005-08-25 Sankyo Co Ltd 血管内皮性酸化窒素の合成促進及び／又は内皮性酸化窒素血中濃度の維持・向上剤

Similar Documents

Publication Publication Date Title
JP2010047616A5 (ru)
RU2022100434A (ru) Фармацевтические композиции, содержащие epa и сердечно-сосудистое средство, и способы их применения
JP2007523049A5 (ru)
RS50419B (sr) Sastav koji ne poseduje askorbinsku kiselinu i koji sadrži inhibitor apsorpcije holesterola, hmg-coa reduktaze i stabilizujući agens
CL2011002787A1 (es) Compuestos derivados de 1-cianoetilheterociclilcarboxamida sustituidos, inhibidores de dipeptidilpeptidasa i (dppi) o catepsina c; composicion farmaceutica; combinacion faramceutica; y su uso en el tratamiento del asma, la enfermedad obstructiva cronica o la rinitis alergica.
RU2007126483A (ru) Гетероциклические ингибиторы аспартилпротеазы
WO2007135527A3 (en) Benzimidazolyl compounds
CL2007001597A1 (es) Compuestos derivados de 2-oxo-piridin-1(2h)-il-tiazol, imidazol o tiofen-carboxamida; composicion farmaceutica; y uso para el tratamiento de una enfermedad mediada por la estearoil-coa-desaturasa, tal como sindrome metabolico, hipertension y diabetes
WO2008058897A3 (en) Diphyllin and other lignans as a medicament for v-atpase mediated disease
JP2004537553A5 (ru)
JP2008063322A5 (ru)
JP2005200419A5 (ru)
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
NZ595116A (en) Use of rosuvastatin lactols as medicaments
CL2007000918A1 (es) Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica.
EA201401042A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И КОМБИНИРОВАННОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ ИНГИБИТОРЫ HMG-CoA-РЕДУКТАЗЫ И ФОСФОДИЭСТЕРАЗЫ 4, И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ ЛЕГКИХ
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
EP2137175A4 (en) NOVEL PHENANTHRENNEQUINONE-BASED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR THE TREATMENT OR PREVENTION OF METABOLIC SYNDROME INVOLVING DISEASES
JP2007533759A5 (ru)
JP2007530528A5 (ru)
WO2009099553A3 (en) Use of kinase inhibitor in treatment of atherosclerosis
DE112007001600A5 (de) Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen
CL2007003189A1 (es) Compuestos derivados de indol y benzofurano; composicion farmaceutica; y uso para el tratamiento o la prevencion de la enfermedad de alzheimer.
PE20080175A1 (es) Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolincarboxilico
WO2009145591A3 (en) Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof